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Key questions
What is already known about this subject?
 ► Cardiac rehabilitation (CR) is recognised as integral 
to the comprehensive care of patients with coronary 
heart disease. CR is a process by which patients, 
in partnership with health professionals, are en-
couraged and supported to achieve and maintain 
optimal physical health, with exercise training at the 
centre of rehabilitation provision for CR. There is an 
absence of evidence and consequently inconsisten-
cy in guideline and policy recommendations for the 
use of CR programme for patients with stable angi-
na. American College of Cardiology/American Heart 
Association and European Society of Cardiology 
guidelines recommend CR for patients with cardi-
ac disease, including patients with stable angina. 
The 2017 British Association for Cardiovascular 
Prevention and Rehabilitation guidelines recom-
mend CR for people with established forms of 
cardiovascular disease, including stable angina. 
However, the National Institute for Health and Care 
Excellence do not recommend CR in their clinical 
guidelines for the management of stable angina.
What does this study add?
 ► This systematic review assesses the impact of CR 
for people with stable angina, defined in this review 
as chest pain and associated symptoms precipitat-
ed by activity (eg, running, walking) with minimal 
or non-existent symptoms at rest. The review finds 
exercise-based CR may improve the short-term ex-
ercise capacity of people with stable angina pecto-
ris, based on low-quality evidence. The review finds 
insufficient evidence to determine effectiveness of 
exercise-based CR on clinical relevant outcomes or 
quality of life.
AbstrAct
Objective A systematic review was undertaken to assess 
the effects of exercise-based cardiac rehabilitation (CR) for 
patients with stable angina.
Methods Databases (Cochrane Central Register of 
Controlled Trials, MEDLINE, Embase and CINAHL) were 
searched up to October 2017, without language restriction. 
Randomised trials comparing CR programmes with 
no exercise control in adults with stable angina were 
included. Where possible, study outcomes were pooled 
using meta-analysis. Grading of Recommendations 
Assessment, Development and Evaluation was used to 
assess the quality of evidence. The protocol was published 
on the Cochrane Database of Systematic Reviews.
Results Seven studies (581 patients), with a median of 
12-month follow-up, were included. The effect of exercise-
based CR on all-cause mortality (risk ratio (RR) 1.01, 95 
% CI: 0.18 to 5.67), acute myocardial infarction (RR 0.33, 
95% CI: 0.07 to 1.63) and cardiovascular-related hospital 
admissions (RR 0.14, 95% CI: 0.02 to 1.1) relative to 
control were uncertain. We found low-quality evidence that 
exercise-based CR results in a moderate improvement in 
exercise capacity (standard mean difference 0.45, 95% CI: 
0.20 to 0.70). There was limited and very low-quality 
evidence for the effect of exercise-based CR on health-
related quality of life (HRQoL), adverse events and costs. 
No data were identified on cost-effectiveness or return to 
work.
Conclusions Exercise-based CR may improve the short-
term exercise capacity of patients with stable angina 
pectoris. Well-designed randomised controlled trials 
are needed to definitely determine the impact of CR on 
outcomes including mortality, morbidity, HRQoL, and costs 
in the population of patients with stable angina receiving 
contemporary medical therapy.
IntROduCtIOn
With increasing numbers of patients living 
longer with symptomatic coronary heart 
disease (CHD), the effectiveness and accessi-
bility of health services for patients with CHD 
have never been more important. Cardiac 
rehabilitation (CR) is recognised as integral 
to the comprehensive care of patients with 
CHD.1 CR is a process by which patients, in 
partnership with health professionals, are 
encouraged and supported to achieve and 
maintain optimal physical health.2 While 
physical exercise training is at the centre 
of rehabilitation provision for CR, it is now 
accepted that programmes should be compre-
hensive in nature and also include education 
and psychological care, as well as focus on 
health and life-style behaviour change and 
psychosocial well-being.3
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How might this impact on clinical practice?
 ► The impact of exercise-based CR for adults with stable angina is 
uncertain due to insufficient evidence, with the quality of the ev-
idence graded as low to very low. However, it may be associated 
with a moderate increase in exercise capacity compared with no 
exercise control. Well-designed randomised controlled trials are 
required to definitively assess the impact of adding CR to contem-
porary usual care in terms of mortality, morbidity, health-related 
quality of life, and costs.
Stable angina is a form of chronic heart disease asso-
ciated with ill health and increased death rates and is 
defined in this review as chest pain and associated symp-
toms precipitated by activity (eg, running, walking) with 
minimal or non-existent symptoms at rest. It was esti-
mated that in 2013 over 1.3 million people in the UK had 
angina4 and it was thought to affect approximately 112 
million people, or 1.6% of the population worldwide.5 
Although clinical guidelines consistently recommend 
referral for CR for post-myocardial infarction (MI) and 
patients with heart failure (HF), advice for patients with 
stable angina is less clear. The American College of Cardi-
ology/American Heart Association give a Class I recom-
mendation that medically supervised CR programmes 
and physician-directed, home-based programme are 
offered to at-risk patients with stable CHD including 
those with stable angina, at first diagnosis.6 Similarly, 
the European Society of Cardiology recommends that 
people with stable CHD, including stable angina, should 
undergo ‘moderate-to-vigorous intensity aerobic exercise 
training ≥3 times a week and for 30 min per session’.7 
However, National Health and Care Excellence (NICE) 
guideline for the management of stable angina (CG126) 
states that there is ‘no evidence to suggest that CR is clini-
cally or cost-effective for managing stable angina’.8
To inform current practice and policy, we therefore 
sought to undertake a systematic review and meta-anal-
ysis of randomised controlled trials (RCTs) to assess 
the effects of exercise-based CR versus usual care on 
mortality, morbidity, hospital admissions, exercise 
capacity, health-related quality of life (HRQoL), adverse 
events and return to work for adults with stable angina.
MetHOds
We conducted and reported this systematic review in 
accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses statement and the 
Cochrane Handbook for Interventional Reviews.9 The 
protocol was published on the Cochrane Database of 
Systematic Reviews.10
searches
We adapted the search strategy based on the Cochrane 
systematic review of exercise-based CR for CHD.11 We 
searched databases using a strategy combining selected 
Medical Subject HeadingsMeSH terms and free-text 
terms relating to exercise-based rehabilitation and stable 
angina, with filters applied to limit to RCTs. Electronic 
searches of the Cochrane Central Register of Controlled 
Trials, MEDLINE, EMBASE and CINAHL plus others (see 
online supplementary document A) were performed. 
Databases were searched up to September 2016 with no 
language or other restrictions, and then updated with 
a further search up to October 2017. Trial registers ( 
www. who. int/ ictrp/ en and  clinicaltrials. gov) were also 
checked, in addition to reference lists of all eligible 
studies and other published systematic reviews.
study selection
We included randomised trials (individual or cluster) 
directly comparing CR programmes with a no exercise 
control or usual care comparison. The study popula-
tion included adults with stable or exertional angina 
(effort-induced chest discomfort), who were being 
treated with medical anti-anginal therapy and who may 
have had a MI, coronary artery bypass graft (CABG) or 
percutaneous coronary intervention (PCI). We excluded 
patients in the immediate period following such an event 
that is, within 3 months of previous MI, CABG or PCI. We 
also excluded patients with unstable angina (pain at rest) 
and those with refractory angina for whom revascularisa-
tion was planned.
Studies with one or more of the following outcome 
measures with ≥6 month-follow-up were included: 
mortality (cardiac and overall); morbidity (reinfarction, 
revascularisation or cardiac-related hospitalisation); 
exercise capacity; HRQoL, adverse events (withdrawal 
from the trial or exercise programme); return to work. 
Selection of studies involved the initial screening of titles 
and abstracts, followed by an assessment of the full-text 
reports of all potentially relevant trials. Two authors (AD 
and LA) independently assessed trials for inclusion and 
where there was a disagreement, the opinion of a third 
author (RST, GH or MG) was sought.
data extraction and risk of bias assessment
The following information was extracted: study design, 
participants (baselinecharacteristics), details of the inter-
vention (including type, frequency, duration and inten-
sity of exercise training and nature of co-interventions), 
length of follow-up and outcome results. We assessed 
study risk of bias using the Cochrane standard criteria9 
(random sequence generation and allocation conceal-
ment, dropouts and withdrawals, outcome blinding, and 
selective reporting) and two further items deemed rele-
vant to this review (balance of groups at baseline and if 
the study groups received comparable care (apart from 
the exercise component of the intervention)). These 
criteria, agreed on in advance by the review authors, have 
not been validated but have been used to assess quality in 
previous CR reviews11–15
Data extraction and risk of bias assessment were 
carried out independently by three authors (LL, JH and 
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Figure 1 Summary of study selection process. RCT, 
randomised controlled trials.
AD). Any disagreements were resolved by consensus and 
decisions were independently checked by a third author 
(RST). Where necessary, authors of included studies were 
contacted for further information (eg, when a study was 
identified as abstract only).
data analysis
Data were analysed in accordance with the Cochrane 
Handbook.9 For dichotomous variables, relative risks 
(RRs) and 95% CIs were calculated for each outcome, 
and for continuous variables, mean differences (MDs) 
and 95% CIs were calculated. Given the variety of 
outcome measures reported for exercise capacity, to 
allow us to pool findings across studies, between-group 
results for each study were expressed as a standard MD 
(SMD). Where differences between groups for each indi-
vidual trial were not reported, we calculated p values for 
the differences.
We explored heterogeneity among the included studies 
qualitatively (by comparing the study characteristics) and 
quantitatively (using the χ2 test of heterogeneity and 
I2 statistic). Where appropriate, an overall estimate of 
treatment effect was obtained by combining the results 
from included studies for each outcome. We employed a 
random-effects model where there was formal evidence 
of statistical heterogeneity (ie, χ2 test p value<0.10 and 
I2 statistic of 50%–90%). For outcomes with lower levels 
of statistical heterogeneity, we applied both fixed and 
random effects models, reporting fixed-effects results 
unless there was a difference in statistical inference, 
where we reported the most conservative random-effects 
model. We sought to explore small-study bias and the 
potential for publication bias using funnel plot and the 
Egger test16
Analyses were undertake using Review Manager Soft-
ware V.5.3 (Nordic Cochrane Group, Copenhagen, 
Denmark).
summary of findings table
Two reviewers (LL and RST) independently employed 
the Grading of Recommendations Assessment, Develop-
ment and Evaluation (GRADE) approach17 to interpret 
result findings. We used the five GRADE considerations 
(study limitations, consistency of effect, imprecision, 
indirectness and publication bias) to assess the quality 
of a body of evidence from studies that contributed data 
to the meta-analyses and narrative summaries for the 
pre-specified outcomes. Any discrepancies in judgements 
were resolved through discussion. One reviewer (LL) 
used GRADEpro GDT 2015 to import data from Review 
Manager to create a ‘Summary of findings’ table using 
the following pre-specified outcomes: all-cause mortality; 
MI; all-cause hospital admissions; HRQoL, return to work 
and exercise capacity.
Results
study selection
Figure 1 summarises the screening process resulting in 
eight publications across seven RCTs included in the 
review.
Characteristics of included studies
The seven RCTs included a total of 581 patients with 
stable angina. A summary of study characteristics is shown 
in tables 1 and 2.
Risk of bias
Overall risk of bias was judged to be poor, most studies 
being insufficiently reported to fully assess their potential 
risk of bias (see figure 2). The reporting of details tended 
to be poorer in studies published prior to 2000.18–20 
Details of selection bias (random allocation sequence 
generation and concealment) and reporting bias were 
particularly poorly reported. Only two studies stated they 
took measures to blind outcome assessment.18 21 Loss to 
follow-up or dropout as well as whether groups received 
the same co-interventions appeared to vary considerably 
across studies. Where reported, losses to follow-up and 
drop-out were relatively high, ranging from 15% to 58% 
across studies. The majority of trials were judged to be of 
low risk of bias in terms of the risk associated with groups 
being unbalanced at baseline.
Impact of CR on outcomes
Mortality and morbidity
Three studies19 20 22 (195 participants) reported a total of 
four all-cause deaths with a pooled RR of 1.01 (95% CI: 
0.18 to 5.67, I2=0%, fixed effects). We are uncertain if CR 
has little or no effect on all-cause mortality due to very 
low-quality evidence (Summary of findings table 3). One 
study (Schuler 1992)20 reported cardiovascular-related 
mortality in two participants in the CR group and none 
in the control.
Morbidity
Three studies19–21 (254 participants) reported on the 
incidence of MI with a total of six events. There was a 
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Table 1 Summary of individual studies
Study
Participants 
(number and 
% men)
Intervention, 
comparator 
and setting Exercise prescripti0m Outcomes Follow-up Country/setting
Devi et al 
201423
94 stable angina 
pectoris; 74% 
men
Home-based 
online web-based 
intervention
Dose: Individualised daily exercise 
(most commonly walking)
Length of session: Not reported
Frequency: Daily
Intensity: Moderate
Total duration: 6 weeks
HRQoL and anxiety and 
depression
6 months UK, single centre
Hambrecht et 
al 200421
101 classes I to III 
angina pectoris;
100% men
Home-based 
aerobic training 
(bicycle ergometer)
Dose: 48×7×20 min
Length of session: 20 min
Frequency: Daily
Intensity: Not reported
Total duration: 12 months
Angina symptoms 
(CCS), exercise capacity, 
revascularisations, MI, 
cost- effectiveness, 
combined clinical 
endpoint (death 
cardiac, stroke, CABG, 
PCI, AMI, worsening 
angina with objective 
evidence resulting in 
hospitalisation)
12 months Germany, single 
centre
Jiang et al 
2007
167 first 
hospitalised with 
angina pectoris 
or MI;
71.2% men
Hospital-based 
patient/family 
education and 
home-based 
rehabilitation care
Dose: Not reported
Length of session: Not reported
Frequency: Not reported
Intensity: Not reported
Total duration: 12 weeks
None relevant to this 
review
6 months China, single centre
Manchanda et 
al 200022
42 chronic stable 
angina pectoris 
and coronary 
artery disease 
(CAD); 100% men
Home-based 
yoga lifestyle 
intervention 
programme
Dose: 48×7×90 min
Length of session: 90 min
Frequency: Daily
Intensity: Moderate
Total duration: 12 months
All-cause mortality, 
severity of angina, 
revascularisation, 
exercise capacity
12 months India, single centre
Raffo et al 
198018
24 stable angina 
pectoris; 88% 
men
Hospital-based 
aerobic training 
(Canadian Air Force 
Programme)
Dose: 24×7×11
Length of session: 11–12 min (daily)
Frequency: Daily (at home)
Intensity: Training started at 
lowest physical capacity level, and 
progressed by increasing this level 
according to their age and sex.
Total duration: 6 months
Exercise capacity 6 months Country not reported, 
single centre
Schuler et al 
199220
113 stable angina 
pectoris; 100% 
men
Home-based 
aerobic training 
(bicycle ergometer)
Dose: 48×7×30 min (daily exercise) 
plus 48×2×60 min (weekly exercise)
Length of session: 30 min minimum
Frequency: Daily
Intensity: 75% maximal heart rate 
during symptom-limited exercise
Total duration: 12 months
All-cause mortality, 
MI, revascularisations, 
exercise capacity, 
adverse events
12 months Germany, single 
centre
Todd et al 
199119
40 chronic 
stable angina >6 
months duration
Home-based 
aerobic training 
(Canadian Air Force 
Programme)
Dose: 48×7×11
Length of session: 11 min
Frequency: Daily
Intensity: Increasing intensity with no 
limit on maximum exercise level
Total duration: 12 months
All-cause mortality, MI, 
exercise capacity
12 months UK, single centre
AMI, acute myocardial infarction; CABG, coronary artery bypass graft; CCS, Canadian Cardiovascular Society; HRQoL, health-related 
quality of life; MI, myocardial infarction; PCI, percutaneous coronary intervention.
pooled RR for risk of MI of 0.33 (95% CI: 0.07 to 1.63, 
I2=0%, fixed effects). We are uncertain if CR has little or 
no effect on the incidence of MI due to very low-quality 
evidence (Summary of findings table 3).
Three studies20–22 (256 participants) reported on the 
incidence of revascularisations with a total of 28 events. 
In total, six revascularisations were reported among the 
CR groups in the three studies, and 22 in the control 
groups, with a pooled RR for risk of revascularisations of 
0.27 (95% CI: 0.11 to 0.64, I2=0%, fixed effects). We are 
uncertain if CR has little or no effect on the incidence 
of revascularisations due to very low-quality evidence 
(Summary of findings table 3).
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Table 2 Summary of study characteristics
Number of studies (%) or 
median (range)
Study characteristics 
  Publication year 
   1980–1999 3
   2000–2009 3
   2010 onwards 1
  Study location 
   Europe 5
   Australasia 2
   Single centre 7
   Sample size 126 (24–167)
   Duration of follow-up 9.4 months (6–12)
  Comparator 
   Usual medical care 6
   PCI 1
Population characteristics
  Sex 
   Males only 4
   Both males and females 3
  Age (years) 56.6 (50–66.2)
Intervention characteristics
   Intervention type 
   Exercise-only programme 4
   Comprehensive programme 3
  Duration of intervention (months) 57.5 (1.5–12)
  Nature of intervention 
   Aerobic only 7
   Aerobic and resistance 0
  Dose of intervention 
   Duration 57.5 months (1.5–12)
   Frequency 1–7 sessions/week
   Length 11–90 min/session
   Intensity  ► 70%–75% of maximal heart 
rate
 ► ‘Moderate’ intensity
  Setting 
   Centre-based only 1
   Combination of centre- and 
home-based
3
   Home-based only 2
PCI, percutaneous coronary intervention.
Figure 2 Risk of bias summary: review authors' judgements 
about each risk of bias item for each included study. + 
(green), low risk of bias; ? (yellow), unclear risk of bias; − 
(red), high risk of bias.
One study21 (101 participants) reported that one CR 
participant and seven control participants experienced 
cardiovascular-related hospital admissions (RR 0.14, 95% 
CI: 0.02 to 1.10). We are uncertain if CR has little or no 
effect on the incidence of cardiovascular-related hospital 
admissions due to very low-quality evidence (Summary of 
findings table 3). None of the included studies reported 
all-cause hospital admissions.
Exercise capacity
Five studies18–22 (267 participants) reported exercise 
capacity with a range of validated measures (peak oxygen 
uptake and exercise duration) (figure 3). CR may result 
in a moderate improvement in exercise capacity with CR 
compared with control in the short term (6–12 months 
follow-up) (SMD 0.45, 95% CI: 0.20 to 0.70; I2=16%, 
fixed effects) (figure 3) based on low-quality evidence 
(Summary of findings table 3). Studies varied in degree 
of losses to follow-up which ranged from 0%20 to 29%21 in 
the intervention arm.
HRQoL
One study23 (94 participants) reported HRQoL using 
validated disease-specific instruments (Seattle angina 
questionnaire and MacNew questionnaire). Compared 
with control, improvements with CR at the 6-week 
follow-up were seen in emotional score (p=0 .04) and 
angina frequency (p=0.002). Benefits in favour of CR 
in angina frequency (P=0.02) and social HRQoL score 
(p=0.02) were also observed at the 6-month follow-up. We 
are uncertain of the effect of CR on HRQoL due to very 
low-quality evidence (Summary of findings table 3).
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Table 3 Summary of findings table
Outcomes
Anticipated absolute effects* 
(95% CI)
Relative effect
(95% CI)
No of participants
(studies)
Quality of the 
evidence
(GRADE)
Risk with usual 
care
Risk with 
exercise-based 
CR
All-cause mortality
Follow-up: 12 months
20 per 1000 21 per 1000
(4 to 116)
RR 1.01
(0.18 to 5.67)
195
(3 RCTs)
⨁◯◯◯
Very low*†‡
AMI
Follow-up: 12 months
39 per 1000 13 per 1000
(3 to 64)
RR 0.33
(0.07 to 1.63)
254
(3 RCTs)
⨁◯◯◯
Very low†‡§
Exercise capacity assessed 
using a variety of outcomes 
including VO2 max and duration 
of exercise
Follow-up: range 6 months to 
12 months
The mean exercise capacity in the 
intervention groups was 0.45 SD higher(0.2 
higher to 0.7 higher)
– 267
(5 RCTs)
⨁⨁◯◯
Low¶**
Cardiovascular hospital 
admissions assessed with: 
Combined clinical endpoint 
(cardiac death, stroke, CABG, 
PCI, AMI, worsening angina 
with objective evidence 
resulting in hospitalisation)
Follow-up: 12 months
Risk with usual care 140 per 1000
Risk with exercise-based CR 20 per 1000 
(2–154)
RR 0.14
(0.02 to 1.1)
101
(1 RCT)
⨁◯◯◯
Very low†††‡‡
HRQoL assessed with: Seattle 
angina questionnaire and The 
MacNew questionnaire
Follow-up: range 6 weeks to 6 
months
One study showed improvement in 
emotional score at 6 week follow-up, and 
benefits in angina frequency and social 
HRQoL score at 6 months follow-up
Not estimable 94
(1 RCT)
⨁◯◯◯
VERY LOW§§‡‡
Return to work No studies were found that looked at return 
to work.
– – –
Adverse events
Follow-up: 12 months
For example, skeletomuscular 
injury
Only one study looked at adverse events 
and reported that there were no adverse 
events during the exercise-based CR.
Not estimable 101
(1 RCTs)
⨁◯◯◯
Very low †††‡‡
* The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative 
effect of the intervention (and its 95% CI)
*Some concerns with random sequence generation, allocation concealment, blinding of outcome assessment and selective reporting; bias 
likely, therefore quality of evidence downgraded by one level.
†Some concern with applicability to review question as participants in all studies were limited to middle-aged men, therefore quality of 
evidence downgraded by one level.
‡Imprecise due to small number of participants (less than 300) and CIs including potential for important harm or benefit as 95% CI crosses 
RR of 0.75 and 1.25, therefore quality of evidence downgraded by two levels.
§Some concern with random sequence generation, allocation concealment, blinding of outcome assessment, high loss to follow-up, 
selective reporting and unbalanced groups at baseline; serious bias likely, therefore quality of evidence downgraded by two levels.
¶Some concern with random sequence generation, allocation concealment, blinding of outcome assessment, selective reporting and 
unbalanced groups at baseline; bias likely, therefore quality of evidence downgraded by one level.
**Imprecise due to small number of participants (less than 300), therefore quality of evidence downgraded by one level.
††Some concerns with random sequence generation, allocation concealment and selective reporting; bias likely, therefore quality of evidence 
downgraded by one level.
‡‡Imprecise due to very small number of participants therefore quality of evidence downgraded by two levels.
§§Some concerns with blinding of outcome assessment, selective reporting and groups not receiving comparable care; bias likely, therefore 
quality of evidence downgraded by one level.
AMI, acute myocardial infarction; CABG, coronary artery bypass graft; CR, cardiac rehabilitation; GRADE, Grading of Recommendations 
Assessment, Development and Evaluation; HRQoL, health-related quality of life; PCI, percutaneous coronary intervention; RCT, randomised 
controlled trial.
Severity of angina
One study22 (42 participants) reported a reduction in 
mean New York Heart Association (NYHA) score from 
baseline to 1-year follow-up (2.6–1.4, p<0.0001) with 
CR and an increase in mean NYHA in control (2.3–2.9, 
p≤0.004). Another study21 (101 participants) reported an 
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Figure 3 Exercise capacity with exercise-based CR versus 
no exercise for stable angina. CR, cardiac rehabilitation.
improvement in angina severity assessed by mean Cana-
dian Cardiovascular Society score in both CR (1.5–0.4, 
p<0.001) and control (1.7–0.7, p<0.001). We assessed 
the evidence as very low‐quality using GRADE because 
of concerns about risk of bias (random sequence genera-
tion, allocation concealment, blinding of outcome assess-
ment, selective reporting, high losses to follow‐up and 
unbalanced groups at baseline), concerns about applica-
bility to review question (participants in all studies were 
limited to middle‐aged men) and concerns about impre-
cision (small number of participants). Data could not be 
pooled in a meta‐analysis because of scales used to report 
outcome measures (ie, NYHA is categorical while CCS is 
continuous).
Adverse events
Adverse events were only reported in one study21 (101 
participants). The authors reported ‘no adverse events’ 
during the exercise training programme in the CR group 
(summary of findings in table 3).
Healthcare costs
One study21 (101 participants) reported a difference in 
mean participant healthcare costs in favour of CR (CR: 
US$3708 vs control: US$6086, p<0.0001). These costs 
included hospitalisations, repeat vascularisations, any 
other cardiovascular events plus the costs of the provi-
sion of the CR exercise training programme. We assessed 
this evidence as very low‐quality using GRADE because 
of concerns about risk of bias (random sequence gener-
ation, allocation concealment, high losses to follow‐up 
and selective reporting), concerns about applicability to 
review question (participants in all studies were limited 
to middle‐aged men) and concerns about imprecision 
(small number of participants). We are uncertain of the 
effect of CR on healthcare costs due to very low-quality 
evidence.
Return to work
None of the included studies reported on return to work 
(summary of findings in table 3)
small study bias
There were insufficient (<10 RCTs) studies to assess small 
study bias using Funnel plot or Egger test.
dIsCussIOn
This systematic review identified seven RCTs in 581 
patients with a confirmed diagnosis of stable angina 
that compared exercise-based CR with a no exercise 
control. Meta-analysis and GRADE analysis showed there 
may be an improvement in exercise capacity following 
CR compared with control in the short term (up to 12 
months follow-up, low-quality evidence). However, there 
was insufficient evidence to be able to definitely assess 
impact of CR on mortality, morbidity, or HRQoL.
The limited evidence base for CR for stable angina 
identified by this review is in contrast to that reported 
for post-MI, following coronary revascularisation, and 
in patients with HF. A Cochrane meta-analysis of exer-
cise-based CR for CHD identified 63 RCTs in 14 486 
patients, the majority following MI or coronary revascular-
isation. Compared with no-exercise control, the authors 
reported that CR reduced the risk of cardiovascular 
mortality (risk ratio (RR) 0.74, 95% CI 0.64 to 0.86 and 
hospital admission (RR 0.82, 95% CI 0.70 to 0.96) and 
improved HRQoL.11 A systematic review and meta-anal-
ysis comparing the effects of home-based and supervised 
centre-based CR found similar benefits in terms of clin-
ical and HRQoL outcomes at equivalent cost for patients 
with HF and following MI and revascularisation.24 The 
precise mechanisms by which CR may improve mortality 
in people with CHD has not been fully elucidated. Exer-
cise training has been shown to have direct benefits on 
the heart and coronary vasculature, including autonomic 
tone, endothelial function, myocardial oxygen demand, 
coagulation and clotting factors, inflammatory markers, 
and the development of coronary collateral vessels.25–27 
However, it has been suggested that approximately half 
of the 28% reduction in cardiac mortality in people 
with CHD may also be mediated via the indirect effects 
of exercise through improvements in the risk factors for 
atherosclerotic disease (ie, smoking, blood pressure and 
total cholesterol).28
A recent review that focused on contemporary exer-
cise-based CR found no improvement in all-cause 
mortality and potential benefit on hospital admissions.29
A recent Cochrane review from 201930 of exercise-based 
CR identified 44 RCTs that included 5783 people with HF. 
The findings show important benefits of exercise-based 
rehabilitation that include a probable reduction in the 
risk of overall hospital admissions in the short term (RR: 
0.7, 95% CI 0.6 to 0.83), as well as the potential for reduc-
tion in HF admissions (RR: 0.59 95% CI 0.42 to 0.84) 
compared with usual care control. The effect of exer-
cise-based rehabilitation on HRQoL is uncertain due to 
very low-quality evidence. Exercise-based rehabilitation 
may make little or no difference in all-cause mortality in 
trials with follow-up less than 12 months.
strengths and limitations
We believe this to be the first systematic review and 
meta-analysis to specifically assess the impact of CR in 
patients with stable angina. Strengths of this review 
include extensive literature searches, consideration of 
RCTs, application of Cochrane review methodology and 
consideration of a wide range of outcomes. However, 
a major limitation was the small number of RCTs and 
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patients included in the studies. It was therefore not 
possible to assess potential small study effects and publi-
cation bias. Trials generally recruited primarily younger 
middle-aged men,19–22 limiting external generalisability. 
A number of the trials were in patient populations with 
poorly defined baseline characteristics in terms of their 
angiographic coronary disease and left ventricular ejec-
tion fraction and were not receiving contemporary 
medical therapy (ie, antiplatelet, antianginal and revas-
cularisation therapies).
Implications for clinical practice and future research
It is estimated that stable angina is prevalent in over 1.3 
million people in the UK,4 and in approximately 112 
million people, or 1.6% of the population worldwide.5 
The findings of this review support NICE clinical guid-
ance that there is currently insufficient evidence to 
conclude whether CR is clinically effective or cost-effec-
tive for stable angina.
Adequately powered, high-quality, multi-centre 
randomised trials of exercise-based CR in patients with 
stable angina receiving contemporary medical care are 
required. Such trials should seek to compare CR to 
contemporary usual care, assessing outcomes that include 
symptom burden with validated angina questionnaires 
and HRQoL measures, report clinical events including 
hospital admissions, all-cause mortality, and, costs and 
cost-effectiveness.
COnClusIOns
The results of this systematic review and meta-analysis 
show that exercise-based CR may improve short-term 
exercise capacity in patients with stable angina pectoris. 
There is insufficient evidence to draw conclusions for 
any other outcome. Given the limited body of available 
evidence, well-designed RCTs in a contemporary patient 
population are required to definitely assess the impact of 
adding CR to usual care in terms of mortality, morbidity, 
HRQoL and costs.
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